We look forward to seeing you!
Join us for a hands-on demo and see augmented intelligence at its best- Radiologists remain in the driver’s seat with AI as the copilot.
Join us for a hands-on demo and see augmented intelligence at its best- Radiologists remain in the driver’s seat with AI as the copilot.
Unlock the potential for your department and improve workflows, quantitative metrics, and reporting in clinical practice and clinical trials.
Augmented intelligence at its best- radiologists remain in the driver’s seat with AI as the co-pilot, as it should be.
A clear, concise report that’s generated automatically as you interact with the images replaces dictated, unstructured text-based reports- providing a standardized longitudinal view of the patient.
No more scrolling through images trying to find lesions mentioned in prior reports or to review annotations made by a preliminary reader. Allow Co-pilot to assist in navigating through studies, increasing efficiency and accuracy.
The AI Metrics Platform was validated in a multi-institutional study with 24 radiologists and 20 oncologic providers that compared the effectiveness of AI Metrics to current methods (manual tumor measurements and dictated reports) for advanced cancer image interpretation and reporting. Increase efficiency, turnaround time, data quality, and standardization with AI Metrics. [read more]
Guided workflows ensure adherence to therapy response assessment criteria (e.g., RECIST 1.1, Lugano 2014)
Establish or enhance an existing Tumor Metrics Core Lab to provide image analysis services
Allows radiologists to complete the standard of care and clinical trial reads simultaneously- no more wasted time, lack of context, or addendum requests
Currently used by multiple NCI-designated Cancer Centers
Coordinate clinical trial reads for multiple ongoing clinical trials
Advanced reader assignment per clinical trial or per timepoint, by name or speciality.
Supports blinded reads, adjudication, primary reads, peer review, addendums.
Meet sponsors’ regulatory requirements: FDA 510(k), 21.CFR.11, HIPAA, ISO 62304, ISO 14971, ISO 13485.
Complete audit trail for the creation of every single lesion, not just the final report
Requires readers to provide justification for changes made to a report after initial signoff
Integrates seamlessly with your clinical trial and data management systems- API and custom deployments available
Guided workflows for cancer screening and staging (e.g., LI-RADS, Lung-RADS, Fleischner)
Track any image finding over time with freeform workflows
Forces follow up of incidental findings, ensuring nothing gets lost between timepoints or different readers
Graphical reports with translation capabilities supports effective communication between providers and patients, no matter the language or health literacy level
Integrates into your current workflow with direct communication (DICOM, HL7) with PACS, RIS, EMR
Radiomics features and lesion data exported in machine- and human-readable formats
ROI exports available for every 2D segmentation in AI Metrics, whether its part of a clinical trial read or a dedicated research project
Fuels novel biomarker development and research
Rapidly annotate images to create training datasets for AI algorithms
Founder
Co-founder
Chief Operating Officer
Co-founder
Head of Product
Vice President of Sales
Global Markets Advisor
Patented technology (US. Pat. Nos. 10,219,768 9,826,951 9,931,093 10,413,266 10,743,829; E.P. Pat. No. 3,292,51).
© Copyright AI Metrics
